Wlaź P, Roliński Z, Kleinrok Z, Czuczwar S J
Department of Pharmacology, Veterinary Faculty, School of Agriculture, Lublin, Poland.
Pharmacol Biochem Behav. 1994 Nov;49(3):609-13. doi: 10.1016/0091-3057(94)90076-0.
The effects of chronic administration of aminophylline (AMPH; 50 mg/kg, twice daily for 14 consecutive days) were studied on both antielectroshock efficacy of diazepam (DZP) and convulsive activity of AMPH in mice. AMPH injected acutely at a dose of 50 mg/kg significantly reduced anticonvulsant action of DZP elevating ED50 from 10.9 (control) to 15.9 mg/kg (p < 0.01). After the administration of AMPH for 3 days, ED50 value was still higher compared with control. Chronic treatment with AMPH resulted in further increase of ED50 of DZP, which was 20.2 mg/kg, and this elevation was significant not only when compared with saline-treated animals, but also with acute and 3-day administration of the xanthine (p < 0.01, 0.05, and 0.001, respectively). Therefore, no tolerance to this AMPH-mediated effect was found, and even an enhancing influence was observed. On the other hand, chronic treatment with AMPH decreased convulsive activity of AMPH elevating ED50 for induction of clonic seizures from 218 to 252 mg/kg (p < 0.01). The remaining seizure parameters were unaffected. Furthermore, in both cases pharmacokinetic interactions were excluded, at least in terms of total plasma levels of the drugs. The results suggest that the mechanisms governing AMPH-induced reversal of the anticonvulsant efficacy of DZP qualitatively differ from those underlying AMPH-induced convulsions. Moreover, these data support the claim that AMPH should be avoided in patients suffering from different types of epilepsy.
研究了慢性给予氨茶碱(AMPH;50mg/kg,每日两次,连续14天)对小鼠地西泮(DZP)抗电休克疗效和AMPH惊厥活性的影响。以50mg/kg的剂量急性注射AMPH可显著降低DZP的抗惊厥作用,使半数有效量(ED50)从10.9(对照)升高至15.9mg/kg(p<0.01)。给予AMPH 3天后,ED50值仍高于对照。AMPH的慢性治疗导致DZP的ED50进一步升高,为20.2mg/kg,这种升高不仅与盐水处理的动物相比有显著差异,而且与黄嘌呤的急性和3天给药相比也有显著差异(分别为p<0.01、0.05和0.001)。因此,未发现对这种AMPH介导的效应产生耐受性,甚至观察到增强作用。另一方面,AMPH的慢性治疗降低了AMPH的惊厥活性,使阵挛性惊厥诱导的ED50从218mg/kg升高至252mg/kg(p<0.01)。其余惊厥参数未受影响。此外,在这两种情况下,至少就药物的总血浆水平而言,排除了药代动力学相互作用。结果表明,AMPH诱导DZP抗惊厥疗效逆转的机制在性质上不同于AMPH诱导惊厥的机制。此外,这些数据支持了在患有不同类型癫痫的患者中应避免使用AMPH的观点。